399 related articles for article (PubMed ID: 20203165)
21. Bisphenol A in chronic kidney disease.
Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
[TBL] [Abstract][Full Text] [Related]
22. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
23. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
24. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
25. Effect of the hemodialysis membrane on the inflammatory reaction in vivo.
Schindler R; Boenisch O; Fischer C; Frei U
Clin Nephrol; 2000 Jun; 53(6):452-9. PubMed ID: 10879665
[TBL] [Abstract][Full Text] [Related]
26. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
27. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
Ouseph R; Hutchison CA; Ward RA
Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
[TBL] [Abstract][Full Text] [Related]
28. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
[TBL] [Abstract][Full Text] [Related]
29. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
Nensel U; Röckel A; Hillenbrand T; Bartel J
Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
[TBL] [Abstract][Full Text] [Related]
30. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
31. The evaluation of increase in hemodialysis frequency on C-reactive protein levels and nutritional status.
Rashidi AA; Soleimani AR; Nikoueinejad H; Sarbolouki S
Acta Med Iran; 2013 Mar; 51(2):119-24. PubMed ID: 23585319
[TBL] [Abstract][Full Text] [Related]
32. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
Haufe CC; Eismann U; Deppisch RM; Stein G
Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
[TBL] [Abstract][Full Text] [Related]
33. [Markers of inflammation and large artery compliance in patients with chronic renal failure].
Stompor T; Rajzer M; Sułowicz W; Dembińska-Kieć A; Janda K; Kawecka-Jaszcz K; Wójcik K; Tabor B; Zdzienicka A; Janusz-Grzybowska E
Pol Merkur Lekarski; 2006 Aug; 21(122):111-4; discussion 115-6. PubMed ID: 17144091
[TBL] [Abstract][Full Text] [Related]
34. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
35. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients.
Kara M; Gurluler E; Cakır U
Ren Fail; 2015; 37(8):1293-6. PubMed ID: 26399977
[TBL] [Abstract][Full Text] [Related]
36. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
[TBL] [Abstract][Full Text] [Related]
38. Effect of a single hemodialysis session on inflammatory markers.
Bitla AR; Reddy PE; Manohar SM; Vishnubhotla SV; Pemmaraju Venkata Lakshmi Narasimha SR
Hemodial Int; 2010 Oct; 14(4):411-7. PubMed ID: 20955274
[TBL] [Abstract][Full Text] [Related]
39. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
Tanaka H; Nishikawa O; Yukawa S; Yoshimoto M; Nishide I
Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981
[TBL] [Abstract][Full Text] [Related]
40. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]